0.9708
price down icon3.88%   -0.0392
pre-market  시장 영업 전:  .97   -0.0008   -0.08%
loading
전일 마감가:
$1.01
열려 있는:
$1
하루 거래량:
1.28M
Relative Volume:
0.88
시가총액:
$111.96M
수익:
$13.45M
순이익/손실:
$-178.23M
주가수익비율:
-0.5884
EPS:
-1.65
순현금흐름:
$-132.53M
1주 성능:
-2.92%
1개월 성능:
-10.94%
6개월 성능:
+7.54%
1년 성능:
-71.86%
1일 변동 폭
Value
$0.961
$1.00
1주일 범위
Value
$0.9403
$1.03
52주 변동 폭
Value
$0.6611
$3.795

Fate Therapeutics Inc Stock (FATE) Company Profile

Name
명칭
Fate Therapeutics Inc
Name
전화
858.875.1803
Name
주소
12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA
Name
직원
181
Name
트위터
@fatethx
Name
다음 수익 날짜
2025-08-08
Name
최신 SEC 제출 서류
Name
FATE's Discussions on Twitter

FATE을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
FATE
Fate Therapeutics Inc
0.9708 116.48M 13.45M -178.23M -132.53M -1.65
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
381.87 96.56B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
449.58 60.08B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
555.51 61.15B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
711.09 44.66B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
328.71 36.23B 3.81B -644.79M -669.77M -6.24

Fate Therapeutics Inc Stock (FATE) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-11-18 업그레이드 BofA Securities Underperform → Neutral
2024-06-17 업그레이드 Piper Sandler Neutral → Overweight
2023-03-27 재개 Wells Fargo Equal Weight
2023-01-24 다운그레이드 H.C. Wainwright Buy → Neutral
2023-01-06 다운그레이드 BMO Capital Markets Outperform → Market Perform
2023-01-06 다운그레이드 BofA Securities Buy → Underperform
2023-01-06 다운그레이드 Cowen Outperform → Market Perform
2023-01-06 다운그레이드 Piper Sandler Overweight → Neutral
2023-01-06 다운그레이드 Stifel Buy → Hold
2023-01-06 다운그레이드 Truist Buy → Hold
2023-01-06 다운그레이드 Wedbush Outperform → Neutral
2023-01-03 다운그레이드 Guggenheim Buy → Neutral
2022-12-22 다운그레이드 Oppenheimer Outperform → Perform
2022-12-15 개시 Goldman Sell
2022-11-04 재개 Cantor Fitzgerald Overweight
2022-10-10 개시 Canaccord Genuity Buy
2022-08-18 재개 Wells Fargo Overweight
2022-07-28 개시 Needham Hold
2022-07-11 업그레이드 BMO Capital Markets Market Perform → Outperform
2022-06-03 개시 Robert W. Baird Neutral
2022-02-11 재개 BMO Capital Markets Market Perform
2021-12-15 업그레이드 Wedbush Neutral → Outperform
2021-12-07 개시 Cowen Outperform
2021-11-09 업그레이드 Citigroup Neutral → Buy
2021-08-26 개시 Morgan Stanley Equal-Weight
2021-06-07 업그레이드 H.C. Wainwright Neutral → Buy
2021-05-07 업그레이드 Wedbush Neutral → Outperform
2021-04-26 재개 Jefferies Buy
2021-02-26 개시 BofA Securities Buy
2021-02-26 다운그레이드 Wedbush Outperform → Neutral
2021-02-11 다운그레이드 Citigroup Buy → Neutral
2021-01-27 재개 H.C. Wainwright Neutral
2020-05-13 개시 H.C. Wainwright Buy
2020-03-04 개시 Barclays Overweight
2020-01-09 다운그레이드 BMO Capital Markets Outperform → Market Perform
2019-12-30 재확인 Mizuho Buy
2019-12-09 업그레이드 Wells Fargo Market Perform → Outperform
2019-11-12 개시 SunTrust Buy
2019-11-06 다운그레이드 Wells Fargo Outperform → Market Perform
2019-10-01 개시 Stifel Buy
2019-08-09 개시 BTIG Research Buy
2019-07-22 개시 Cantor Fitzgerald Overweight
2019-07-12 개시 Oppenheimer Outperform
2019-06-13 개시 Mizuho Buy
2019-06-07 개시 ROTH Capital Neutral
2019-05-31 개시 Guggenheim Buy
2019-05-24 재개 Citigroup Buy
2019-03-28 개시 SVB Leerink Outperform
2019-01-03 다운그레이드 Stephens Overweight → Equal-Weight
2018-11-05 개시 Jefferies Buy
2018-08-01 개시 Citigroup Buy
2018-03-06 다운그레이드 H.C. Wainwright Buy → Neutral
모두보기

Fate Therapeutics Inc 주식(FATE)의 최신 뉴스

pulisher
06:35 AM

What technical signals suggest for Fate Therapeutics Inc. stockPortfolio Gains Summary & Reliable Price Breakout Alerts - newser.com

06:35 AM
pulisher
01:54 AM

Is Fate Therapeutics Inc. stock trading at a premium valuationJuly 2025 Price Swings & Consistent Growth Equity Picks - newser.com

01:54 AM
pulisher
Sep 25, 2025

Fate Therapeutics (NASDAQ:FATE) Stock Crosses Below 200-Day Moving AverageHere's What Happened - MarketBeat

Sep 25, 2025
pulisher
Sep 24, 2025

Fate Therapeutics Inc. stock daily chart insightsJuly 2025 Selloffs & Weekly Watchlist for Consistent Profits - newser.com

Sep 24, 2025
pulisher
Sep 23, 2025

Stem Cell Co. Beats Investor Suit Over Failed Janssen Collab - Law360

Sep 23, 2025
pulisher
Sep 23, 2025

Fate Therapeutics Gets J&J Partnership Class Action Tossed Again - Bloomberg Law News

Sep 23, 2025
pulisher
Sep 22, 2025

Top chart patterns to watch in Fate Therapeutics Inc.Insider Buying & AI Enhanced Trade Execution Alerts - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

Evaluating Fate Therapeutics Inc. with trendline analysisWeekly Trend Summary & AI Driven Price Predictions - newser.com

Sep 22, 2025
pulisher
Sep 20, 2025

Fate Therapeutics, Inc. $FATE Shares Bought by Acadian Asset Management LLC - MarketBeat

Sep 20, 2025
pulisher
Sep 20, 2025

Applying big data sentiment scoring on Fate Therapeutics Inc.2025 EndofYear Setup & Growth Focused Stock Pick Reports - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

Options Flow: Can Fate Therapeutics Inc ride the EV waveIndex Update & Weekly Setup with ROI Potential - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Aug PreEarnings: Is Fate Therapeutics Inc. subject to activist investor interestTrend Reversal & Fast Entry High Yield Stock Tips - خودرو بانک

Sep 20, 2025
pulisher
Sep 19, 2025

Will Fate Therapeutics Inc. rebound enough to break even2025 Technical Overview & Daily Stock Trend Watchlist - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Aug PostEarnings: Is Fate Therapeutics Inc in a bullish channel2025 Retail Activity & Consistent Growth Equity Picks - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Using Ichimoku Cloud for Fate Therapeutics Inc. technicalsEarnings Beat & Technical Entry and Exit Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Insider Buy: What is the dividend yield of Fate Therapeutics IncQuarterly Portfolio Review & AI Driven Stock Price Forecasts - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

MACD Signal: Is Fate Therapeutics Inc subject to activist investor interest2025 Macro Impact & Fast Moving Market Watchlists - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Signal strength of Fate Therapeutics Inc. stock in tech scannersStop Loss & Accurate Entry/Exit Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Breakout Zone: Is Fate Therapeutics Incs ROIC above industry averageGlobal Markets & Real-Time Market Trend Scan - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Short Covering: Is Fate Therapeutics Inc subject to activist investor interestJuly 2025 Breakouts & Growth Focused Stock Reports - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Should you wait for a breakout in Fate Therapeutics Inc.2025 Top Decliners & Safe Capital Growth Tips - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Fed Meeting: Is Fate Therapeutics Inc stock risky to hold nowWeekly Investment Recap & Risk Managed Investment Strategies - خودرو بانک

Sep 19, 2025
pulisher
Sep 16, 2025

Portfolio Shifts: Is Fate Therapeutics Inc showing insider buyingMarket Movers & Weekly Stock Performance Updates - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Analyst Upgrade: Is Fate Therapeutics Inc showing insider buyingWeekly Investment Summary & AI Driven Stock Price Forecasts - khodrobank.com

Sep 16, 2025
pulisher
Sep 16, 2025

Trading Recap: Is Fate Therapeutics Inc in a bullish channelJuly 2025 Setups & Free AI Powered Buy and Sell Recommendations - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Risk Report: Will Fate Therapeutics Inc outperform the market in YEARMarket Movers & Verified Chart Pattern Signals - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Jacobs Levy Equity Management Inc. Acquires 616,336 Shares of Fate Therapeutics, Inc. $FATE - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

What analysts say about Fate Therapeutics Inc stockJuly 2025 Recap & High Yield Stock Recommendations - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Hedge Fund Bets: Can Fate Therapeutics Inc lead its sector in growth2025 Technical Patterns & Smart Swing Trading Techniques - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Momentum Shift: Is Fate Therapeutics Inc stock risky to hold now2025 Fundamental Recap & Reliable Breakout Forecasts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Activity Recap: What is the dividend yield of Fate Therapeutics Inc2025 Major Catalysts & Safe Capital Allocation Plans - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Stock Report: Will Fate Therapeutics Inc outperform the market in YEAR2025 Institutional Moves & Technical Buy Zone Confirmation - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

How to read the order book for Fate Therapeutics Inc.Global Markets & Community Shared Stock Ideas - newser.com

Sep 15, 2025
pulisher
Sep 14, 2025

Should you hold or exit Fate Therapeutics Inc. nowJuly 2025 EndofMonth & Weekly Top Gainers Alerts - newser.com

Sep 14, 2025
pulisher
Sep 13, 2025

Walleye Capital LLC Sells 1,010,806 Shares of Fate Therapeutics, Inc. $FATE - MarketBeat

Sep 13, 2025
pulisher
Sep 12, 2025

Nuveen LLC Purchases Shares of 379,088 Fate Therapeutics, Inc. $FATE - MarketBeat

Sep 12, 2025
pulisher
Sep 10, 2025

Leerink Partnrs Analysts Raise Earnings Estimates for FATE - MarketBeat

Sep 10, 2025
pulisher
Sep 09, 2025

Will Fate Therapeutics Inc. outperform small cap indexesJuly 2025 Chart Watch & Comprehensive Market Scan Reports - Lancaster City Council

Sep 09, 2025
pulisher
Sep 08, 2025

RSI + MACD Show Convergence for Fate Therapeutics Inc.2025 Dividend Review & Weekly Stock Breakout Alerts - beatles.ru

Sep 08, 2025
pulisher
Sep 08, 2025

Analysts Set Fate Therapeutics, Inc. (NASDAQ:FATE) Price Target at $3.30 - MarketBeat

Sep 08, 2025
pulisher
Sep 06, 2025

Price Floor Holding on Fate Therapeutics Inc. — Rebound PossibleJuly 2025 Summary & Verified Short-Term Trading Plans - beatles.ru

Sep 06, 2025
pulisher
Sep 06, 2025

Using data models to predict Fate Therapeutics Inc. stock movementEarnings Recap Summary & Consistent Return Investment Signals - Newser

Sep 06, 2025
pulisher
Sep 05, 2025

Volume spikes in Fate Therapeutics Inc. stock – what they meanGlobal Markets & Risk Adjusted Swing Trade Ideas - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Heatmap analysis for Fate Therapeutics Inc. and competitorsJuly 2025 Gainers & Free Safe Entry Trade Signal Reports - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Visual trend scoring systems applied to Fate Therapeutics Inc.Market Trend Report & AI Optimized Trading Strategy Guides - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

What MACD and RSI say about Fate Therapeutics Inc.July 2025 Macro Moves & Reliable Volume Spike Trade Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Leerink Partners Sticks to Its Buy Rating for Fate Therapeutics (FATE) - The Globe and Mail

Sep 05, 2025
pulisher
Sep 05, 2025

Layoff Tracker: AC Immune To Cut 30% of Workforce - BioSpace

Sep 05, 2025
pulisher
Sep 05, 2025

Can technical indicators confirm Fate Therapeutics Inc.’s reversalSwing Trade & Stock Market Timing Techniques - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

What are analysts’ price targets for Fate Therapeutics Inc.2025 Market Overview & Smart Swing Trading Alerts - خودرو بانک

Sep 05, 2025
pulisher
Sep 04, 2025

Key metrics from Fate Therapeutics Inc.’s quarterly dataEarnings Recap Summary & Safe Investment Capital Preservation Plans - Newser

Sep 04, 2025

Fate Therapeutics Inc (FATE) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$34.90
price down icon 2.43%
$81.66
price down icon 2.97%
$28.84
price down icon 2.07%
$98.08
price down icon 1.67%
$135.59
price down icon 3.84%
biotechnology ONC
$328.71
price down icon 0.34%
자본화:     |  볼륨(24시간):